Original Biomedicals Co (ROCO:6483) Research & Development: NT$47.26 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6483 Original Biomedicals Co Ltd ROCO:6483
32 GF Score
Price NT$13.15
! 2 Warning Signs
View Full Analysis

What is Original Biomedicals Co Research & Development?

Original Biomedicals Co ROCO:6483 -1.87% 32 Research & Development is NT$47.26 Mil as of Dec. 2025. GuruFocus rates ROCO:6483 with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Original Biomedicals Co's Research & Development for the six months ended in Dec. 2025 was NT$25.66 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$47.26 Mil.

Original Biomedicals Co  (ROCO:6483) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Original Biomedicals Co Research & Development Related Terms

Original Biomedicals Co Research & Development Historical Data

* Premium members only.

The historical data trend for Original Biomedicals Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Original Biomedicals Co Research & Development Chart

Original Biomedicals Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 107.83 22.91 24.71 33.05 47.26

Original Biomedicals Co Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.75 13.21 19.84 21.60 25.66
ROCO:6483
32GF Score
Original Biomedicals Co Ltd ROCO:6483
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Original Biomedicals Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$47.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$47.26 Mil mean?
Original Biomedicals Co (ROCO:6483) has a Research & Development of NT$47.26 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Original Biomedicals Co and its competitors.
Is Original Biomedicals Co's Research & Development too high?
Original Biomedicals Co's current Research & Development is NT$47.26 Mil. Overall, Original Biomedicals Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's Research & Development compare to ZTS and UTHR?
Original Biomedicals Co's Research & Development of NT$47.26 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Original Biomedicals Co and its competitors. Original Biomedicals Co's current Research & Development is NT$47.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current Research & Development of NT$47.26 Mil. The current Research & Development is NT$47.26 Mil. Original Biomedicals Co's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current Research & Development is NT$47.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Original Biomedicals Co Business Description

Address No. 9, Nanke 2nd Road, 2 Floor-1, Xinshi District, Tainan, TWN, 74147
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
32GF Score

Get the complete analysis for ROCO:6483

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.15
Price